INDIVIDUAL ARTICLE: Update on Combined Topical Products for Treating Acne: Leaping From Dyads
This article discusses formulation strategies that allow for the coadministration of active drugs and reviews all commercially available fixed-combination topical acne treatments. J Drugs Dermatol. 2024;23:4(Suppl 2):s4-10.PMID:38564404 | DOI:10.36849/JDD.SF378083b (Source: Journal of Drugs in Dermatology)
Source: Journal of Drugs in Dermatology - April 2, 2024 Category: Dermatology Authors: Naiem T Issa Leon Kircik Source Type: research
Human Clinical Trials Using Topical Bakuchiol Formulations for the Treatment of Skin Disorders: A Systematic Review
Conclusion: Trials lack methodologic rigor, which introduces a high risk of bias in reported outcomes. The use of combination topical formulations containing bakuchiol limits the comparison of bakuchiol’s efficacy with retinoids. Continued research with an improved trial design is needed.J Drugs Dermatol. 2024;23(4): doi:10.36849/JDD.7763.PMID:38564402 | DOI:10.36849/JDD.7763 (Source: Journal of Drugs in Dermatology)
Source: Journal of Drugs in Dermatology - April 2, 2024 Category: Dermatology Authors: James E Fanning Shayan A McGee Omer I Ibrahim Source Type: research
Treatments for Moderate-to-Severe Acne Vulgaris: A Systematic Review and Network Meta-analysis
CONCLUSIONS: Based on this SLR/NMA, topical triple-agent FDC gel was the most efficacious and safe treatment for moderate-to-severe acne. J Drugs Dermatol. 2024;23(4): doi:10.36849/JDD.8148.PMID:38564399 | DOI:10.36849/JDD.8148 (Source: Journal of Drugs in Dermatology)
Source: Journal of Drugs in Dermatology - April 2, 2024 Category: Dermatology Authors: Julie C Harper Hilary Baldwin Saswata Paul Choudhury Deepti Rai Bikramaditya Ghosh Md Sohai Aman Abhra R Choudhury Sekhar Kumar Dutta Debalina Dey Subrata Bhattacharyya Tina Lin George Joseph Ankur A Dashputre Jerry K L Tan Source Type: research
A Silymarin Antioxidant Serum Improves Facial Acne Alone and as Part of a Treatment Regimen
CONCLUSION: Silymarin is shown in clinical testing to have significant benefits in reducing lipid peroxidation, oiliness, and PIH, and in improving key markers of skin aging. Additionally, the serum can be used alone or as an adjunctive treatment in acne therapy to further benefit aging, acne-prone skin. J Drugs Dermatol. 2024;23(4): doi:10.36849/JDD.8120.PMID:38564394 | DOI:10.36849/JDD.8120 (Source: Journal of Drugs in Dermatology)
Source: Journal of Drugs in Dermatology - April 2, 2024 Category: Dermatology Source Type: research
INDIVIDUAL ARTICLE: Update on Combined Topical Products for Treating Acne: Leaping From Dyads
This article discusses formulation strategies that allow for the coadministration of active drugs and reviews all commercially available fixed-combination topical acne treatments. J Drugs Dermatol. 2024;23:4(Suppl 2):s4-10.PMID:38564404 | DOI:10.36849/JDD.SF378083b (Source: Journal of Drugs in Dermatology)
Source: Journal of Drugs in Dermatology - April 2, 2024 Category: Dermatology Authors: Naiem T Issa Leon Kircik Source Type: research
Human Clinical Trials Using Topical Bakuchiol Formulations for the Treatment of Skin Disorders: A Systematic Review
Conclusion: Trials lack methodologic rigor, which introduces a high risk of bias in reported outcomes. The use of combination topical formulations containing bakuchiol limits the comparison of bakuchiol’s efficacy with retinoids. Continued research with an improved trial design is needed.J Drugs Dermatol. 2024;23(4): doi:10.36849/JDD.7763.PMID:38564402 | DOI:10.36849/JDD.7763 (Source: Journal of Drugs in Dermatology)
Source: Journal of Drugs in Dermatology - April 2, 2024 Category: Dermatology Authors: James E Fanning Shayan A McGee Omer I Ibrahim Source Type: research
Treatments for Moderate-to-Severe Acne Vulgaris: A Systematic Review and Network Meta-analysis
CONCLUSIONS: Based on this SLR/NMA, topical triple-agent FDC gel was the most efficacious and safe treatment for moderate-to-severe acne. J Drugs Dermatol. 2024;23(4): doi:10.36849/JDD.8148.PMID:38564399 | DOI:10.36849/JDD.8148 (Source: Journal of Drugs in Dermatology)
Source: Journal of Drugs in Dermatology - April 2, 2024 Category: Dermatology Authors: Julie C Harper Hilary Baldwin Saswata Paul Choudhury Deepti Rai Bikramaditya Ghosh Md Sohai Aman Abhra R Choudhury Sekhar Kumar Dutta Debalina Dey Subrata Bhattacharyya Tina Lin George Joseph Ankur A Dashputre Jerry K L Tan Source Type: research
A Silymarin Antioxidant Serum Improves Facial Acne Alone and as Part of a Treatment Regimen
CONCLUSION: Silymarin is shown in clinical testing to have significant benefits in reducing lipid peroxidation, oiliness, and PIH, and in improving key markers of skin aging. Additionally, the serum can be used alone or as an adjunctive treatment in acne therapy to further benefit aging, acne-prone skin. J Drugs Dermatol. 2024;23(4): doi:10.36849/JDD.8120.PMID:38564394 | DOI:10.36849/JDD.8120 (Source: Journal of Drugs in Dermatology)
Source: Journal of Drugs in Dermatology - April 2, 2024 Category: Dermatology Source Type: research
Treatments for Moderate-to-Severe Acne Vulgaris: A Systematic Review and Network Meta-analysis
CONCLUSIONS: Based on this SLR/NMA, topical triple-agent FDC gel was the most efficacious and safe treatment for moderate-to-severe acne. J Drugs Dermatol. 2024;23(4): doi:10.36849/JDD.8148.PMID:38564399 | DOI:10.36849/JDD.8148 (Source: Journal of Drugs in Dermatology)
Source: Journal of Drugs in Dermatology - April 2, 2024 Category: Dermatology Authors: Julie C Harper Hilary Baldwin Saswata Paul Choudhury Deepti Rai Bikramaditya Ghosh Md Sohai Aman Abhra R Choudhury Sekhar Kumar Dutta Debalina Dey Subrata Bhattacharyya Tina Lin George Joseph Ankur A Dashputre Jerry K L Tan Source Type: research
Human Clinical Trials Using Topical Bakuchiol Formulations for the Treatment of Skin Disorders: A Systematic Review
Conclusion: Trials lack methodologic rigor, which introduces a high risk of bias in reported outcomes. The use of combination topical formulations containing bakuchiol limits the comparison of bakuchiol’s efficacy with retinoids. Continued research with an improved trial design is needed.J Drugs Dermatol. 2024;23(4): doi:10.36849/JDD.7763.PMID:38564402 | DOI:10.36849/JDD.7763 (Source: Journal of Drugs in Dermatology)
Source: Journal of Drugs in Dermatology - April 2, 2024 Category: Dermatology Authors: James E Fanning Shayan A McGee Omer I Ibrahim Source Type: research
INDIVIDUAL ARTICLE: Update on Combined Topical Products for Treating Acne: Leaping From Dyads
This article discusses formulation strategies that allow for the coadministration of active drugs and reviews all commercially available fixed-combination topical acne treatments. J Drugs Dermatol. 2024;23:4(Suppl 2):s4-10.PMID:38564404 | DOI:10.36849/JDD.SF378083b (Source: Journal of Drugs in Dermatology)
Source: Journal of Drugs in Dermatology - April 2, 2024 Category: Dermatology Authors: Naiem T Issa Leon Kircik Source Type: research
A Silymarin Antioxidant Serum Improves Facial Acne Alone and as Part of a Treatment Regimen
CONCLUSION: Silymarin is shown in clinical testing to have significant benefits in reducing lipid peroxidation, oiliness, and PIH, and in improving key markers of skin aging. Additionally, the serum can be used alone or as an adjunctive treatment in acne therapy to further benefit aging, acne-prone skin. J Drugs Dermatol. 2024;23(4): doi:10.36849/JDD.8120.PMID:38564394 | DOI:10.36849/JDD.8120 (Source: Journal of Drugs in Dermatology)
Source: Journal of Drugs in Dermatology - April 2, 2024 Category: Dermatology Source Type: research
Treatments for Moderate-to-Severe Acne Vulgaris: A Systematic Review and Network Meta-analysis
CONCLUSIONS: Based on this SLR/NMA, topical triple-agent FDC gel was the most efficacious and safe treatment for moderate-to-severe acne. J Drugs Dermatol. 2024;23(4): doi:10.36849/JDD.8148.PMID:38564399 | DOI:10.36849/JDD.8148 (Source: Journal of Drugs in Dermatology)
Source: Journal of Drugs in Dermatology - April 2, 2024 Category: Dermatology Authors: Julie C Harper Hilary Baldwin Saswata Paul Choudhury Deepti Rai Bikramaditya Ghosh Md Sohai Aman Abhra R Choudhury Sekhar Kumar Dutta Debalina Dey Subrata Bhattacharyya Tina Lin George Joseph Ankur A Dashputre Jerry K L Tan Source Type: research
Human Clinical Trials Using Topical Bakuchiol Formulations for the Treatment of Skin Disorders: A Systematic Review
Conclusion: Trials lack methodologic rigor, which introduces a high risk of bias in reported outcomes. The use of combination topical formulations containing bakuchiol limits the comparison of bakuchiol’s efficacy with retinoids. Continued research with an improved trial design is needed.J Drugs Dermatol. 2024;23(4): doi:10.36849/JDD.7763.PMID:38564402 | DOI:10.36849/JDD.7763 (Source: Journal of Drugs in Dermatology)
Source: Journal of Drugs in Dermatology - April 2, 2024 Category: Dermatology Authors: James E Fanning Shayan A McGee Omer I Ibrahim Source Type: research
